skinatan 1 mg/ml solucion cutanea
skin care pharma gmbh - metilprednisolona aceponato - soluciÓn cutÁnea - 1 mg/ml - metilprednisolona aceponato 1 mg - metilprednisolona, aceponato de
normoreum 400 mg comprimidos recubiertos con pelicula
laboratorios normon s.a. - harpagophytum exto seco - comprimido recubierto con pelÍcula - 400 mg - harpagophytum exto seco 400 mg - otros fármacos para desórdenes del sistema musculoesquelético
pantoprazol accord healthcare 40 mg polvo para solucion inyectable efg
accord healthcare s.l.u. - pantoprazol sodico sesquihidrato - polvo para soluciÓn inyectable - 40 mg - pantoprazol sodico sesquihidrato 40 mg - pantoprazol
gemcitabina pharm v solutions 1000 mg polvo para solucion para perfusion efg
pharm v solutions limited - gemcitabina hidrocloruro - excipientes: hidroxido de sodio (e-524),manitol (e-421),acetato de sodio trihidrato - antimetabolitos - análogos de las pirimidinas - gemcitabina
gemcitabina pharm v solutions 200 mg polvo para solucion para perfusion efg
pharm v solutions limited - gemcitabina hidrocloruro - excipientes: hidroxido de sodio (e-524),manitol (e-421),acetato de sodio trihidrato - antimetabolitos - análogos de las pirimidinas - gemcitabina
irinotecan fair-med healthcare 20 mg/ml concentrado para solucion para perfusion efg
fair-med healthcare gmbh - irinotecan hidrocloruro trihidrato - excipientes: sorbitol,hidroxido de sodio (e-524) - otros agentes antineoplÁsicos - otros agentes antineoplásicos - irinotecán
lansoprazol optimal regulatory solutions 15 mg capsulas duras gastrorresistentes efg
optimal regulatory solutions, s.l. - lansoprazol - excipientes: azucar , esferas de - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - lansoprazol
lansoprazol optimal regulatory solutions 30 mg capsulas duras gastrorresistentes efg
optimal regulatory solutions, s.l. - lansoprazol - excipientes: azucar , esferas de - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - lansoprazol
oxaliplatino accord healthcare 5 mg/ml polvo para solucion para perfusion efg
accord healthcare, s.l.u - oxaliplatino - excipientes: lactosa monohidrato - otros agentes antineoplÁsicos - compuestos del platino - oxaliplatino
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.